<?xml version="1.0" encoding="UTF-8"?>
<glossary>
 <title>Abbreviations</title>
 <def-list>
  <def-item>
   <term>PAAD</term>
   <def>
    <p id="Par5">Pancreatic adenocarcinoma</p>
   </def>
  </def-item>
  <def-item>
   <term>TIME</term>
   <def>
    <p id="Par6">Tumor immune microenvironment</p>
   </def>
  </def-item>
  <def-item>
   <term>OS</term>
   <def>
    <p id="Par7">Overall survival</p>
   </def>
  </def-item>
  <def-item>
   <term>RFS</term>
   <def>
    <p id="Par8">Relapse-free survival</p>
   </def>
  </def-item>
  <def-item>
   <term>IGP</term>
   <def>
    <p id="Par9">In-group-proportion</p>
   </def>
  </def-item>
  <def-item>
   <term>ICPs</term>
   <def>
    <p id="Par10">Immune checkpoints</p>
   </def>
  </def-item>
  <def-item>
   <term>ICD</term>
   <def>
    <p id="Par11">Immunogenic cell death</p>
   </def>
  </def-item>
  <def-item>
   <term>DCs</term>
   <def>
    <p id="Par12">Dendritic cells</p>
   </def>
  </def-item>
  <def-item>
   <term>APC</term>
   <def>
    <p id="Par13">Antigen presenting cells</p>
   </def>
  </def-item>
  <def-item>
   <term>TIICs</term>
   <def>
    <p id="Par14">Tumor infiltrating immune cells</p>
   </def>
  </def-item>
  <def-item>
   <term>KO</term>
   <def>
    <p id="Par15">Knockout</p>
   </def>
  </def-item>
  <def-item>
   <term>ICB</term>
   <def>
    <p id="Par16">Immune checkpoint blockage</p>
   </def>
  </def-item>
  <def-item>
   <term>TMB</term>
   <def>
    <p id="Par17">Tumor mutation burden</p>
   </def>
  </def-item>
  <def-item>
   <term>CA125</term>
   <def>
    <p id="Par18">Carbohydrate antigen 125</p>
   </def>
  </def-item>
  <def-item>
   <term>CA199</term>
   <def>
    <p id="Par19">Carbohydrate antigen 199</p>
   </def>
  </def-item>
  <def-item>
   <term>ICGC</term>
   <def>
    <p id="Par20">International Cancer Genome Consortium</p>
   </def>
  </def-item>
  <def-item>
   <term>PDAC</term>
   <def>
    <p id="Par21">Pancreatic ductal adenocarcinoma</p>
   </def>
  </def-item>
  <def-item>
   <term>TCGA</term>
   <def>
    <p id="Par22">The Cancer Genome Atlas</p>
   </def>
  </def-item>
  <def-item>
   <term>ssGSEA</term>
   <def>
    <p id="Par23">Single-sample GSEA</p>
   </def>
  </def-item>
  <def-item>
   <term>KRAS</term>
   <def>
    <p id="Par24">KRAS proto-oncogene GTPase</p>
   </def>
  </def-item>
  <def-item>
   <term>p53</term>
   <def>
    <p id="Par25">Tumor protein p53</p>
   </def>
  </def-item>
  <def-item>
   <term>EFNB2</term>
   <def>
    <p id="Par26">Ephrin B2</p>
   </def>
  </def-item>
  <def-item>
   <term>MET</term>
   <def>
    <p id="Par27">MET proto-oncogene receptor tyrosine kinase</p>
   </def>
  </def-item>
  <def-item>
   <term>TMOD3</term>
   <def>
    <p id="Par28">Tropomodulin 3 
     <italic>Homo sapiens</italic>
    </p>
   </def>
  </def-item>
  <def-item>
   <term>TPX2</term>
   <def>
    <p id="Par29">TPX2 microtubule nucleation factor</p>
   </def>
  </def-item>
  <def-item>
   <term>WNT7A</term>
   <def>
    <p id="Par30">Wingless-type MMTV integration site family member 7A</p>
   </def>
  </def-item>
  <def-item>
   <term>MDSCs</term>
   <def>
    <p id="Par31">Myeloid-derived suppressor cells</p>
   </def>
  </def-item>
 </def-list>
</glossary>
